The LumiraDx Dual-Target SARS-CoV-2 STAR Complete multiplex assay is intended for the detection and differentiation of nucleic acid from two distinct genes from the SARS-CoV-2 genome in nasopharyngeal or anterior nasal swab from individuals suspected of COVID-19.
Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets.
Supporting healthier lives, for individuals, communities and wider society.
Enabling responsive, personal relationships between patients and care teams.
Controlling and reducing costs to help ease pressure on healthcare budgets.